对TRK抑制剂及其结构-活性关系的研究进展
Yao-Yao Ye1, Ruo-Xuan Xu2, Wen Zhang2
1College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, PR China; Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Deqing, 313200, PR China.
神经受体氨酸受体激酶 (NTRK) 基因融合驱动癌症,但很难在早期发现. 目前正在进行研究,以克服耐药性并改善针对NTRK驱动的恶性瘤的向治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 神经受体受体激酶 (NTRK) 对于神经细胞功能至关重要.
- NTRK基因融合导致TRK蛋白异常,促进癌症的发展.
- NTRK是一个关键的癌症独立和可用药的目标.
研究的目的:
- 审查NTRK基因融合机制和特征.
- 总结目前针对NTRK基因融合的向治疗方法.
- 为开发新的,有效的抑制剂提供基础.
主要方法:
- 关于NTRK基因融合的文献综述.
- 对已销售和正在研究的向治疗药物的分析.
- 药物耐药机制的检查.
主要成果:
- 在常见的瘤中,NTRK融合是罕见的,但在罕见的瘤中是常见的,使诊断复杂化.
- 对TRK抑制剂的耐药性降低了治疗疗效.
- 向疗法显示出希望,但面临的阻力挑战.
结论:
- 进一步的研究对于克服耐药性至关重要.
- 开发新的抑制剂对于改善患者的治疗结果至关重要.
- 扩大NTRK基因融合癌症的治疗选择是一个优先事项.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Receptor Tyrosine Kinases
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
